Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-10-011882

Options or other derivatives

  • CFO acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Buck Paul CFO 2010-03-03 Grant or award · Stock Option (Right to Buy) +450,000 450,000 D
Loading xslF345X03/v176500_ex.xml…